XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 15.46%6.38B | -0.55%10.88B | -1.43%5.53B | 0.20%10.94B | 6.26%5.61B | 14.62%10.92B | 18.35%5.28B | 0.96%9.53B | -1.07%4.46B | -5.79%9.44B |
Operating income | 15.46%6.38B | -0.55%10.88B | -1.43%5.53B | 0.20%10.94B | 6.26%5.61B | 14.62%10.92B | 18.35%5.28B | 0.96%9.53B | -1.07%4.46B | -5.79%9.44B |
Cost of sales | -85.51%-2.77B | 5.25%-3.09B | 11.04%-1.49B | -4.69%-3.26B | -17.45%-1.68B | -17.61%-3.11B | -17.16%-1.43B | -4.30%-2.65B | -13.51%-1.22B | 8.28%-2.54B |
Operating expenses | -85.51%-2.77B | 5.25%-3.09B | 11.04%-1.49B | -4.69%-3.26B | -17.45%-1.68B | -17.61%-3.11B | -17.16%-1.43B | -4.30%-2.65B | -13.51%-1.22B | 8.28%-2.54B |
Gross profit | -10.44%3.61B | 1.44%7.79B | 2.67%4.03B | -1.59%7.68B | 2.10%3.93B | 13.47%7.81B | 18.80%3.85B | -0.26%6.88B | -5.62%3.24B | -4.84%6.9B |
Administrative expenses | -2.06%-346M | -1.04%-680M | -5.94%-339M | -8.90%-673M | -11.89%-320M | -10.55%-618M | 6.84%-286M | 10.27%-559M | 8.08%-307M | 11.88%-623M |
Revaluation surplus | -396.68%-715M | 82.39%-62M | 211.06%241M | -176.86%-352M | -135.81%-217M | 106.68%458M | 112.61%606M | -164.56%-6.86B | -335.65%-4.81B | 147.09%10.62B |
-Changes in the fair value of investment property | -396.68%-715M | 82.39%-62M | 211.06%241M | -176.86%-352M | -135.81%-217M | 106.68%458M | 112.61%606M | -164.56%-6.86B | -335.65%-4.81B | 147.09%10.62B |
Special items of operating profit | 26.67%19M | 160.00%13M | 25.00%15M | -91.67%5M | -63.64%12M | 11.11%60M | 22.22%33M | -93.89%54M | -96.91%27M | 784.00%884M |
Operating profit | -34.93%2.57B | 6.03%7.07B | 16.07%3.95B | -13.55%6.66B | -18.97%3.4B | 1,702.29%7.71B | 327.57%4.2B | -102.71%-481M | -130.71%-1.85B | 62.51%17.78B |
Financing income | -20.00%40M | 39.73%102M | 42.86%50M | -10.98%73M | -27.08%35M | 17.14%82M | 37.14%48M | -56.25%70M | -66.35%35M | -65.59%160M |
Financing cost | -46.35%-461M | -34.08%-720M | -18.87%-315M | -5.50%-537M | -11.34%-265M | -129.28%-509M | -180.00%-238M | -54.17%-222M | -30.77%-85M | 87.80%-144M |
Share of profit from joint venture company | 88.57%132M | -16.99%127M | -39.66%70M | 1,192.86%153M | 474.19%116M | 95.19%-14M | 81.44%-31M | -259.02%-291M | -234.68%-167M | -57.93%183M |
Earning before tax | -39.24%2.28B | 3.49%6.57B | 14.16%3.76B | -12.58%6.35B | -17.34%3.29B | 886.36%7.27B | 292.92%3.98B | -105.14%-924M | -133.41%-2.06B | 68.65%17.98B |
Tax | 10.74%-756M | -6.55%-1.66B | -8.17%-847M | 28.94%-1.56B | 29.33%-783M | -73.75%-2.19B | -155.89%-1.11B | 76.66%-1.26B | 41.01%-433M | -296.11%-5.4B |
After-tax profit from continuing operations | -47.54%1.53B | 2.50%4.92B | 16.04%2.91B | -5.52%4.8B | -12.71%2.51B | 332.27%5.08B | 215.06%2.87B | -117.38%-2.19B | -145.88%-2.5B | 35.27%12.58B |
Earning after tax | -47.54%1.53B | 2.50%4.92B | 16.04%2.91B | -5.52%4.8B | -12.71%2.51B | 332.27%5.08B | 215.06%2.87B | -117.38%-2.19B | -145.88%-2.5B | 35.27%12.58B |
Minority profit | -48.00%638M | 1.30%2.1B | 14.89%1.23B | -16.45%2.08B | -21.70%1.07B | 486.02%2.49B | 251.39%1.36B | -111.18%-644M | -152.05%-901M | 43.58%5.76B |
Profit attributable to shareholders | -47.21%888M | 3.42%2.81B | 16.89%1.68B | 4.98%2.72B | -4.58%1.44B | 268.01%2.59B | 194.55%1.51B | -122.61%-1.54B | -143.00%-1.6B | 28.97%6.82B |
Basic earnings per share | -47.58%0.65 | 3.00%2.06 | 16.98%1.24 | 5.26%2 | -4.50%1.06 | 68.14%1.9 | 194.87%1.11 | -77.45%1.13 | -143.01%-1.17 | 29.12%5.01 |
Diluted earnings per share | -47.58%0.65 | 3.00%2.06 | 16.98%1.24 | 5.26%2 | -4.50%1.06 | 68.14%1.9 | 194.87%1.11 | -77.45%1.13 | -143.01%-1.17 | 29.12%5.01 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.